
A third point of attraction was the Greek ecosystem which although emerging from a recession has a great appetite for fast access to new treatments. The country is ripe for innovation and practical changes to the healthcare system
Tags:
Managing Director of MSD Greece, Cyprus & Malta Agata Jakoncic, who also serves as president of Greece’s PhRMA Innovation Forum (PIF), draws on her three decades of industry experience to…
Greek medtech industry veteran Dimitris Nikas outlines what makes him optimistic about the future of Greek healthcare, highlights the areas for systemic improvement and how EU recovery funding could help,…
Angelini Pharma’s Gabriele Jannis draws on his experience in both Russia and Romania to highlight some of the key challenges for European mid-caps like Angelini in Greece, the importance of…
See our Cookie Privacy Policy Here